An Institutional Guide for Formulary Decisions of Biosimilars. [PDF]
Hosp Pharm, 2023 Ismail S +5 more
europepmc +1 more source
Pediatric growth hormone treatment in Italy: A systematic review of epidemiology, quality of life, treatment adherence, and economic impact. [PDF]
PLoS One, 2022 Orso M +7 more
europepmc +1 more source
Building the adult growth hormone deficiency data mart: a Real-World model of AI-driven clinical data extraction in a single Italian center. [PDF]
J Endocrinol InvestVergani E +9 more
europepmc +1 more source
Immune-Mediated Inflammatory Diseases: Addressing Safety Concerns and Enhancing the Accessibility of Biosimilars. [PDF]
Curr Med SciFeiteira CP, Tavares IC, Ribeiro MHL.
europepmc +1 more source
Stability of Refrigerated Medications at Room Temperature: Implications for Transport, Delivery, and Patient Safety. [PDF]
CureusAleidi FA +4 more
europepmc +1 more source
Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy data. [PDF]
Drug Des Devel Ther, 2017 López-Siguero JP +5 more
europepmc +1 more source
Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy. [PDF]
Clinicoecon Outcomes Res, 2019 Foo J +4 more
europepmc +1 more source
Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review. [PDF]
Clinicoecon Outcomes ResFox GE +5 more
europepmc +1 more source